英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
underripe查看　underripe　在百度字典中的解释百度英翻中〔查看〕
underripe查看　underripe　在Google字典中的解释Google英翻中〔查看〕
underripe查看　underripe　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • The selection and use of essential in vitro diagnostics - TRS 1031
    The group also oversees maintenance of the WHO Model List of Essential In Vitro Diagnostics (EDL), which serves as an evidence-based reference point for countries to develop their own national lists to guide how they choose and use IVDs
  • WHO consolidated guidelines on tuberculosis: module 3: diagnosis: rapid . . .
    Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection, third edition ” is the latest document replacing the one issued in 2021 This latest edition includes new recommendations on the use of a new class of diagnostic technologies: targeted next-generation sequencing (NGS) tests for the diagnosis of drug-resistant tuberculosis (TB)
  • Global Diagnostics Coalition - World Health Organization (WHO)
    The GDC is a WHO-managed informal network convening diverse stakeholders to strengthen diagnostics capacity and support coordinated action across health systems It also contributes to advancing other relevant World Health Assembly resolutions and global health priorities related to diagnostics across diseases and health conditions towards universal health coverage and emergency preparedness
  • Landscape analysis of commercially available and pipeline in vitro . . .
    This 2025 report is an update to the first WHO Landscape analysis of commercially available and pipeline in vitro diagnostics for bacterial priority pathogens, published in 2019 The 2019 Landscape analysis concluded that the need for diagnostics included rapid tests that distinguish between bacterial and viral infections, tests for pathogen identification, and tests that detect antimicrobial
  • Ethics and governance of artificial intelligence for health
    The report identifies the ethical challenges and risks with the use of artificial intelligence of health, six consensus principles to ensure AI works to the public benefit of all countries
  • Consolidated guidelines on HIV prevention, testing, treatment, service . . .
    These consolidated guidelines on preventing and treating HIV infection bring together a series of recommendations to promote the highest quality, person-centred delivery of care for people living with and affected by HIV The proposed tools and approaches correspond to the best available standard of care for low-and middle-income countries, as well as for high-income countries – erasing any
  • WHO guidelines on hand hygiene in health care
    The WHO Guidelines on Hand Hygiene in Health Care provide health-care workers (HCWs), hospital administrators and health authorities with a thorough review of evidence on hand hygiene in health care and specific recommendations to improve practices and reduce transmission of pathogenic microorganisms to patients and HCWs The present Guidelines are intended to be implemented in any situation
  • WHO releases new list of essential diagnostics; new recommendations for . . .
    The World Health Organization (WHO) has released its 2023 Essential Diagnostics List (EDL), which is an evidence-based register of in vitro diagnostics (IVD) that supports countries to make national diagnostic choices
  • WHO recommends new diagnostic tools to help end TB
    On World TB Day, the World Health Organization (WHO) is urging countries to accelerate action to end tuberculosis (TB) and expand access to lifesaving services by using new innovations such as diagnostic tests that can be used near the point-of-care and tongue swabs that can help detect the disease faster reaching more people
  • Redefining the HIV response in Africa through local production of . . .
    To boost supply chain resilience and regional self-reliance, WHO has been actively advocating for locally manufactured quality-assured medicines and diagnostics In 2023, a Kenya-based pharmaceutical company became the first African manufacturer to receive WHO prequalification to produce tenofovir disoproxil fumarate, lamivudine and dolutegravir (TLD), a WHO-recommended first-line





中文字典-英文字典  2005-2009